Thrombectomy and thrombolysis--therapeutic alternatives?
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D005069:Evaluation Studies as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013299:Streptodornase and Streptokinase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013927:Thrombosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D013299:Streptodornase and Streptokinase; D014568:Urokinase-Type Plasminogen Activator